This stage of breast cancer is considered incurable and treatment options are limited, with only 15% of patients living beyond five years. CDK4/6 inhibitor Ibrance has been available since 2020 to ...

Pfizer is to make its breast cancer drug Ibrance (palbociclib ... Around 6,000 patients could be eligible for treatment across the UK each year. NICE found that the drug stalled growth of the ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

Over a third of US citizens (about 91 million people) are unable to access quality healthcare if they needed it today, based ...

Learn about how different healthcare providers work together to help breast cancer patients weigh their treatment options.

Oncologists share how to prioritize yourself while undergoing the difficult treatment Getty Despite ongoing advances in breast cancer therapeutics, one thing for certain is that beating it is a ...

Richardson, has published promising findings from the past seven years of research into a new approach for the treatment of ...

Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body ...

First-line Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in mutated, advanced or metastatic non-small cell lung cancer.

The technology, which in the past had been limited by size and cost, provides targeted doses of radiation to tumors, ...